WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • January 3rd, 2011 • Pacira Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS WARRANT CERTIFIES THAT, for value received as consideration pursuant to that certain Note and Warrant Purchase Agreement, dated December 29, 2010, by and among the Company and the Investors named therein (the “Purchase Agreement”), and for other good and valuable consideration the sufficiency of which is hereby acknowledged, (“Holder”) is entitled to purchase up to ( ) fully paid and nonassessable shares of the Company’s common stock, $0.001 par value per share (the “Shares”), at the Exercise Price, all as set forth herein, subject to the provisions and upon the terms and conditions set forth in this Warrant.
